Table 2.

Deterministic patient-level CEA based on subgroup.

Sample	Patient-level outcomes (based on subgroup)					Subgroup outcomes
	Incremental direct medical costs		Incremental QALYs		QALY gain per 100 000 population	Total incremental costs ($)	Total QALYs gained
	Short-term acute model ($)	Postdischarge ($)	Short-term acute model	Postdischarge
HQ1	1586	7374	0.005	0.296	98	120 909 211	4061
HQ2	1586	9190	0.005	0.365	156	339 032 405	11 641
HQ3	1586	10 986	0.005	0.434	250	716 341 025	25 014
HQ4	1586	12 977	0.005	0.510	365	1 886 505 857	66 714
HQ5	1586	15 247	0.004	0.597	586	2 295 149 707	82 082
BQ1	1586	7374	0.005	0.296	121	117 349 372	3942
BQ2	1586	9190	0.005	0.365	191	312 535 672	10 731
BQ3	1586	10 986	0.005	0.434	295	679 915 404	23 742
BQ4	1586	12 977	0.005	0.510	446	1 521 237 961	53 796
BQ5	1586	15 247	0.004	0.597	672	1 480 832 835	52 959
WQ1	1586	7374	0.005	0.296	151	1 548 403 663	52 011
WQ2	1586	9190	0.005	0.365	244	2 451 826 694	84 185
WQ3	1586	10 986	0.005	0.434	382	3 846 518 715	134 316
WQ4	1586	12 977	0.005	0.510	559	5 035 222 809	178 064
WQ5	1586	15 247	0.004	0.597	841	3 482 364 613	124 540
Average/total∗	1586	11 155	0.005	0.440	376	25 834 145 944		907 797

Note. Subgroup costs are estimated by multiplying total incremental costs from the CEA by the number of hospitalized patients per subgroup. Within the model, no rounding was used, and therefore, calculated estimates based on table inputs may slightly vary from reported results.

B indicates non-Hispanic black; CEA, cost-effectiveness analysis; H, Hispanic; Q, quintile (1 = least socially vulnerable; 5 = most socially vulnerable); QALYs, quality-adjusted life-years; SVI, social vulnerability index; W, non-Hispanic white.

^∗Average values are reported for patient-level outcomes and total values are reported for subgroup outcomes.